Related Experiment Video
Updated: Jan 30, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Integrative identification of unexpected kinase-inhibitor interactions in the MAPK-mediated proliferation and
Lei Zhao1, Qun Huang, Shoujin Tian
1Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China. qironggdong@sina.cn.
Abstract:
Kinase-targeted therapy is a new and promising approach to disease treatment. However, some kinase inhibitors have been observed to cause an off-target adverse risk for skeletal system by influencing the growth of osteoblasts. It is known that the proliferation and differentiation of osteoblasts are essentially regulated by MAPK signaling pathway, and many off-target events are considered to influence this pathway. Here, the unexpected MAPK-inhibitor interactions in mouse MC3T3-E1 osteoblastic cells were investigated in detail using an integrative protocol. With bioinformatics analysis we successfully profiled a systematic noncognate interaction spectrum for off-target kinase inhibitors against mouse MAPK kinases, from which 13 potential MAPK-inhibitor interactions were identified. The inhibitors Nilotinib, Dasatinib and Bosutinib were suggested as promising candidates; their cytotoxicity on MC3T3-E1 and inhibitory activity against MAPK kinase were tested at cellular and molecular levels, respectively. We also tested two known MAPK inhibitors SP600125 and SB203580 as positive controls. Consequently, the Dasatinib was found to have high off-target risk for unexpectedly targeting osteoblast MAPK signaling pathway.
Insights
Kinase inhibitors can harm bone growth by affecting osteoblasts. This study found Dasatinib unexpectedly targets the MAPK pathway in osteoblasts, posing a skeletal risk.
Area of Science:
- Pharmacology
- Cell Biology
- Biochemistry
Background:
- Kinase-targeted therapies offer promise but can cause skeletal adverse effects.
- Osteoblast proliferation and differentiation are regulated by the MAPK signaling pathway.
- Off-target kinase inhibitor interactions may disrupt this crucial pathway.
Purpose of the Study:
- To investigate unexpected mitogen-activated protein kinase (MAPK) inhibitor interactions in mouse osteoblastic cells.
- To identify specific kinase inhibitors with potential off-target effects on the MAPK pathway.
- To assess the risk posed by these interactions to osteoblast function.
Main Methods:
- Utilized an integrative protocol combining bioinformatics analysis and experimental validation.
- Performed systematic profiling of noncognate interactions between kinase inhibitors and mouse MAPK kinases.
- Assessed cytotoxicity and inhibitory activity of candidate inhibitors in MC3T3-E1 cells.
Main Results:
- Identified 13 potential MAPK-inhibitor interactions, with Nilotinib, Dasatinib, and Bosutinib as promising candidates.
- Dasatinib demonstrated significant cytotoxicity in MC3T3-E1 cells.
- Dasatinib was confirmed to unexpectedly target the osteoblast MAPK signaling pathway.
Conclusions:
- Dasatinib presents a high off-target risk due to its unexpected interaction with the osteoblast MAPK pathway.
- This finding highlights the importance of evaluating kinase inhibitors for skeletal safety.
- Further research is needed to understand and mitigate these adverse effects.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Integrator and Differentiator
An integrator within an op-amp circuit produces an output directly proportional to the integral of the input signal. This is achieved by replacing the feedback resistor in a typical inverting...
MAPK Signaling Cascades
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
E1 Reaction: Kinetics and Mechanism
E1 Reaction: Stereochemistry and Regiochemistry

